Nalbuphine Hydrochloride
Who holds supplier records for Nalbuphine Hydrochloride? 3 organisations hold a current record for Nalbuphine Hydrochloride: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: United States (1) and China (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 11 Nov 2026. How we read these records
Cite as: PharmaTek, “Nalbuphine Hydrochloride: DMF and CEP holder records”, record as of 11 Nov 2026, pharmatek.co.uk/directory/api/nalbuphine-hydrochloride
Reading the evidence
- 3 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- No company-level GMP certificate matched
No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.
Current records (3)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Nalbuphine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- FRANCOPIA A EUROAPI COActive DMF 21144 · latest filing Jun 2007
- SPECGX LLCUnited StatesActive DMF 23604 · latest filing Apr 2010
- YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTDChinaActive DMF 44144 · latest filing May 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Nalbuphine Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- SANOFI SYNTHELABO INCInactive DMF 6279 · filed Apr 1986
- United States · Inactive DMF 6388 · filed Feb 1986
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Nalbuphine Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201132).
Chemical identity
- IUPAC name
- (4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol;hydrochloride
- Canonical SMILES
- C1CC(C1)CN2CC[C@]34[C@@H]5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O.Cl
- InChIKey
- YZLZPSJXMWGIFH-BCXQGASESA-N
- Synonyms
- EN-2234A, Nalbufine hydrochloride, Nalbuphine hcl, Nalbuphine hydrochloride, NSC-757829, Nubain, En 2234A, Nalbufina clorhidrato, CHEBI:7455, NALBUPHINE HCI, RefChem:57231, EN2234A
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Opioid Agonist/Antagonist
- Mechanism of action
- Competitive Opioid Antagonists; Partial Opioid Agonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Nalbuphine Hydrochloride?
3 organisations hold an active US FDA Type II Drug Master File or a CEP for Nalbuphine Hydrochloride: FRANCOPIA A EUROAPI CO, SPECGX LLC (United States) and YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Nalbuphine Hydrochloride Drug Master Files are active?
FRANCOPIA A EUROAPI CO (DMF 21144), SPECGX LLC (DMF 23604) and YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD (DMF 44144). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Nalbuphine Hydrochloride records mean?
2 organisations have only inactive Type II DMFs for Nalbuphine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Nalbuphine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Nalbuphine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.